ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Rheumatology · J Rheumatol · 2026-08-01

Systematic review of 41 studies (19 RCTs, 6171 patients, meta-analysed) in axial spondyloarthritis on biologics or tsDMARDs: pooled proportion reaching ASDAS inactive disease was 0.24 at 12–24 weeks; odds of inactive disease vs low disease activity were 0.30.

Meta-analysisn = 6,171
Doumeth et al. Achieving Axial Spondyloarthritis Disease Activity Score Inactive Disease Status in Axial Spondyloarthritis in Clinical Trials: A Systematic Review and Metaanalysis
Rheumatology · RMD Open · 2026-06-24

Network meta-analysis of 99 RCTs in rheumatoid arthritis: JAK inhibitors (HAQ MD −0.13) and IL-6 inhibitors (MD −0.13) reduced activity limitation more than TNF inhibitors; no other significant class differences in pain, fatigue or physical or mental health.

Meta-analysisn = 99 trials
van Esveld et al. Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analyses

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.